Peter Attia criticism sparks longevity debate

A YouTube critique of Peter Attia circulated over the weekend, reopening questions about how much evidence sits behind celebrity longevity advice. (youtube.com) (slate.com) Attia is a physician whose 2023 book *Outlive* has sold more than 3 million copies, and his podcast archive shows new episodes on peptides, aging clocks and prostate screening this month. (penguinrandomhouse.com) (peterattiamd.com) His pitch to followers is “healthspan,” a term he helped popularize for the years before disability and chronic disease narrow daily life. Slate reported that message turned him into one of the most visible names in longevity media. (slate.com) The current backlash is tied not only to biohacking claims but also to Attia’s disclosed correspondence with Jeffrey Epstein. CBS News reported on February 2 that Attia apologized after emails surfaced in the Justice Department’s latest Epstein-file release. (cbsnews.com) In that statement, Attia said some messages were “embarrassing, tasteless, and indefensible,” and CBS said he was not accused of criminal wrongdoing. NBC News and Reuters later reported he stepped down from his CBS News contributor role on February 23. (cbsnews.com) (nbcnews.com) (usnews.com) That CBS job had barely begun. The network announced Attia as one of 19 new contributors on January 27, less than a month before his exit. (cbsnews.com 1) (cbsnews.com 2) Bloomberg reported in March that Attia’s name appeared more than 1,700 times in the Epstein document release and described a yearslong relationship that cut against the trust-based image of his brand. (bloomberg.com) The argument over Attia’s science is separate from the Epstein fallout, but it overlaps with it in public. Slate wrote in February that even Attia, often treated as a more careful figure than many wellness influencers, makes prevention and testing claims that go beyond settled evidence. (slate.com) Attia’s own recent output shows he is still trying to frame himself as a translator of research rather than a supplement salesman. His April posts and podcast episodes focus on papers, screening tools and “evaluating the science, safety, and hype” around peptides. (peterattiamd.com 1) (peterattiamd.com 2) The weekend video did not create the credibility fight around Attia. It pushed an existing dispute — over evidence, influence and trust — back into the feed around one of longevity’s biggest names. (youtube.com) (bloomberg.com)